1) Avidan B, Sonnebberg A, Schnell TG, et al:Risk factors of oesophagitis in arthritic patients. Eur J Gastroenterol Hepatol 13:1095-1099, 2001
2) Chan FK, Hung LC, Suen BY, et al:Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N Engl J Med 347:2104-2110, 2002
3) 千葉 勉:高齢者の消化性疾患.日老医誌37:353-359,2010
4) Douthwaite AH, Lond MD, Lintotto GAM:Gastroscopic observation of the effect of aspirin and certain other substances on the stomach. Lancet 232:122-1224, 1938
5) Glise H, Hallerbäck B, Johansson B:Quality-of-life assessments in evaluation of laparoscopic Rosetti fundoplication. Surg Endosc 9(2):183-188;discussion 188-189, 1995
6) Huang JQ, Sridhar S, Hunt RH:Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease:a meta-analysis. Lancet 359(9300):14-22, 2002
7) Kusano M:Development and evaluation of FSSG:frequency scale for the symptoms of GERD. J Gastroenterol 39:888-891, 2004
8) Lai KC, Chu KM, Hui WM, et al:Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Am J Med 118:1271-1278, 2005
9) 森本正好:「アスピリン」胃潰瘍の一例.診断と治療21:1044-1045,1934
10) 日本消化器病学会(編集):消化性潰瘍診療ガイドライン.南江堂,2009
11) Robert A:Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. Adv Prostaglandin Thromboxane Res 2:507-520, 1976
12) 酒井英嗣,遠藤宏樹,中島 淳:わが国のNSAIDs起因性消化管障害.小腸および大腸病変の発生機序.The GI Forefront 10:20-22, 2014
13) Singh G, Ramey DR, Morfeld D, et al:Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 156:1530-1536, 1996